J Rheum Dis.  2023 Jan;30(1):1-2. 10.4078/jrd.22.0047.

A Challenging Target: Persistent Pain During the Remission State in Rheumatoid Arthritis Patients

• Lim DH

• KMID: 2537489
• DOI: http://doi.org/10.4078/jrd.22.0047

Reference

1. Walsh DA, McWilliams DF. 2014; Mechanisms, impact and management of pain in rheumatoid arthritis. Nat Rev Rheumatol. 10:581–92. DOI: 10.1038/nrrheum.2014.64. PMID: 24861185.

2. Vergne-Salle P, Pouplin S, Trouvin AP, Bera-Louville A, Soubrier M, Richez C, et al. 2020; The burden of pain in rheumatoid arthritis: impact of disease activity and psychological factors. Eur J Pain. 24:1979–89. DOI: 10.1002/ejp.1651. PMID: 32841455. PMCID: PMC7692940.

3. Kim HA, Park SY, Shin K. 2022; Implications of persistent pain in patients with rheumatoid arthritis despite remission status: data from the KOBIO registry. J Rheum Dis. 29:215–22. DOI: 10.4078/jrd.22.0005.

4. Shinoda M, Honda T, Ozaki N, Hattori H, Mizutani H, Ueda M, et al. 2003; Nerve terminals extend into the temporomandibular joint of adjuvant arthritic rats. Eur J Pain. 7:493–505. DOI: 10.1016/S1090-3801(03)00021-1. PMID: 14575662.

5. Hess A, Axmann R, Rech J, Finzel S, Heindl C, Kreitz S, et al. 2011; Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A. 108:3731–6. DOI: 10.1073/pnas.1011774108. PMID: 21245297. PMCID: PMC3048151.

6. Basu N, Kaplan CM, Ichesco E, Larkin T, Harris RE, Murray A, et al. 2018; Neurobiologic features of fibromyalgia are also present among rheumatoid arthritis patients. Arthritis Rheumatol. 70:1000–7. DOI: 10.1002/art.40451. PMID: 29439291.

7. Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. 2011; Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 7:216–24. Erratum. DOI: 10.1038/nrrheum.2011.2. PMID: 21283147.

8. Burckhardt CS. 1984; The use of the McGill Pain Questionnaire in assessing arthritis pain. Pain. 19:305–14. DOI: 10.1016/0304-3959(84)90007-1. PMID: 6472875.

9. Sakellariou G, Scirè CA, Adinolfi A, Batticciotto A, Bortoluzzi A, Delle Sedie A, et al. 2020; Differential diagnosis of inflammatory arthropathies by musculoskeletal ultrasonography: a systematic literature review. Front Med (Lausanne). 7:141. DOI: 10.3389/fmed.2020.00141. PMID: 32457913. PMCID: PMC7221062.

10. Lee YC, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Williams DA, et al. 2014; Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors. Arthritis Rheumatol. 66:2006–14. DOI: 10.1002/art.38682. PMID: 24782222. PMCID: PMC4188637.

11. Altawil R, Saevarsdottir S, Wedrén S, Alfredsson L, Klareskog L, Lampa J. 2016; Remaining pain in early rheumatoid arthritis patients treated with methotrexate. Arthritis Care Res (Hoboken). 68:1061–8. DOI: 10.1002/acr.22790. PMID: 26784398. PMCID: PMC5129578.

12. Fautrel B, Zhu B, Taylor PC, van de Laar M, Emery P, De Leonardis F, et al. 2020; Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison. RMD Open. 6:e001131. DOI: 10.1136/rmdopen-2019-001131. PMID: 32371431. PMCID: PMC7299519.